Cardiovascular Diseases Clinical Trial
Official title:
Acute Effects of Beet Extract on Autonomic and Cardiovascular Recovery After Exercise
Dietary NO3 is found in high concentrations in green leafy vegetables and beets. Studies weighing the action of NO3 for ergogenic purposes have found metabolic improvement in skeletal muscle during exercise in hypoxia, lowering blood pressure and increased workload at anaerobic threshold. In a way, the use of nitrate in combination with exercise may assist in autonomic adaptation to multiple stimuli, such as rest, during exercise and during the recovery period. HRV is one of the most practical methods for analyzing the physiological functioning of the ANS, both in the pathological condition of the individual and in the induction of other variables. peak-R (RRI) of consecutive heart beats. This study aims to evaluate the effect of beet extract supplementation in combination with submaximal strength exercise on heart rate variability and cardiovascular parameters of physically active individuals. It is a double-blind randomized crossover clinical trial.
An anamnesis of the participants will be made before the research. Essential information such
as name, gender, age, height, BMI will be collected. Anthropometric measurements will be
acquired according to the recommendations. Volunteers will be properly informed about the
procedures and objectives of this study.
From a pre-established randomization, on the first day of collection volunteers will be
allocated to group I (Placebo) or group II (Beet Extract). In the first intervention the
volunteers allocated in group I will take a capsule containing 600mg of starch, at the end of
this will be provided another capsule containing 600mg of beet extract for the second
intervention. Conversely, group II volunteers will ingest a capsule containing 600mg of beet
extract in the first intervention, and at the end of the experiment, another capsule
containing 600mg of starch will be provided.
Research participants will be advised to consume the capsules within 2 hours of the
procedure, adequate time for digestion, absorption and effect on the body. Prior to testing
will be asked about the use of caffeine or any other type of substance that is described in
the study inclusion and exclusion criteria. Then the collection will proceed.
Participants' blood pressure will be measured before (Rest) and after submaximal strength
exercise during the first recovery time (REC1- 00-05 minutes) at 5 1-minute intervals using
an aneroid sphygmomanometer (Premium®). and stethoscope (Rappaport®). Korotkoff's first and
fifth phase readings were adopted as systolic and diastolic blood pressure, respectively.
Resistance exercise will be performed by performing movements that recruit lower limbs,
emphasizing the quadriceps, posterior leg and buttocks. Training intensity will be defined by
a subjective test of 1 repetition maximum (1RM). The evaluation will take place at a time
before (at least 72 hours) to the data collection, aiming to pre-define and standardize the
load that will be used on the day of the experiment. In this sense, the individuals will be
oriented to test the load in the 4 proposed physical exercises in a total of 10 maximum
repetitions, obtaining 75% of 1 maximum repetition (75% 1RM).
Leg Press 45º - 4 sets x 10 repetitions (75% 1RM) Extender Chair - 4 sets x 10 reps (75% 1RM)
Abductor Chair - 4 sets x 10 repetitions (75% 1RM) Guided Squat - 4 sets x 10 repetitions
(75% 1RM
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|